Furthermore, antibody-mediated inhibition of TGF-β signaling in a mouse model of CRC promotes a rapid and long lasting Th1 response far more potent than checkpoint inhibition and capable of preventing metastasis (173). Here, TGFB1 is linked to colorectal carcinoma.